Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
29 Leser
Artikel bewerten:
(0)

Research and Markets - Global Prenatal Testing & Newborn Screening Market Analysis - Trends, Technologies & Opportunities Report 2016-2021 - Key Vendors: Perkinelmer, Genquest, Identity Genetics

DUBLIN, June 15, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Prenatal Testing & Newborn Screening Market - By Type (Screening & Diagnosis Tests); Technology (Tandem Mass Spectroscopy, Electrophoresis, Enzyme And Immuno Assays, DNA Based Assays); Instrument - Forecast 2016 - 2021." report to their offering.

This comprehensive report analyzes the global prenatal testing and newborn screening market and the key topics all market participants should be aware of. It considers current and future drivers, challenges and opportunities, providing readers with an unrivalled understanding of the market and where it's heading.

Prenatal screening for fetal defects has become a standard part of pregnancy medical care in the past couple of decades. Tests are typically conducted during the first half of pregnancy in order to detect a wide range of genetic and other disorders, and to give women the option of obtaining abortions if in case any defects are diagnosed. While some people believe this as a breakthrough in the prevention or eradications of diseases, it has significantly contributed to the improvement of society as a whole.

Due to the availability of many kinds of tests, parents are currently selecting the safer ones and also the technological developments have generally made the process of testing safe. These tests are also very effective and accurate, with several disorders being detected using single test, thus reducing the need for multiple visits and tests.

Companies Mentioned:

  • Genetrack Biolabs Inc.
  • Verinata Health, Inc.
  • Lifecodexxag
  • Hoffmann-La Roche Ltd.,
  • Bio-Rad Laboratories
  • Masimo Corporation,
  • Perkinelmer Inc.,
  • Genquest, Llc.
  • Identity Genetics, Inc.,
  • Babycenter, L.L.C.

Report Structure:

1. Market Overview

2. Executive Summary

3. Prenatal Testing And Newborn Screening Market Landscape

4. Prenatal Testing And Newborn Screening Market-Forces

5. Prenatal Testing And Newborn Screening Market-Strategic Analysis

6. Prenatal Testing And Newborn Screening Market By Types

7. Prenatal Testing And Newborn Screening Market By Diagonising Technique

8. Prenatal Testing And Newborn Screening Market By Screening Options

9. Prenatal Testing And Newborn Screening Market Bytechnology

10. Prenatal Testing And Newborn Screening Market By Instruments

11. Prenatal Testing And Newborn Screening Market Market-By Geography

12. Prenatal Testing And Newborn Screening Market Market-Entropy

13. Company Profiles

For more information visit http://www.researchandmarkets.com/research/wz8lp9/prenatal_testing

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.